New Retrospective Analysis on Galderma Laboratories’ Differin® Gel, 0.3% in Adult Female Acne Patients

Published: Aug 01, 2013

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

FORT WORTH, Texas--(BUSINESS WIRE)--Galderma Laboratories, L.P. today announced results from a new analysis showing that Differin® (adapalene) Gel, 0.3%, a single agent retinoid, is efficacious in reducing acne lesions in adult women, and has been proven superior in reducing inflammatory lesions in women compared with vehicle gel.1 The data were presented today at the American Academy of Dermatology 2013 Summer Meeting in New York.

Help employers find you! Check out all the jobs and post your resume.

Back to news